These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 18525308

  • 1. Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study.
    Cellini N, Smaniotto D, Scambia G, Luzi S, Balducci M, Ferrandina G, Corvari B, Margariti PA, Valentini V, D'Agostino G.
    Am J Clin Oncol; 2008 Jun; 31(3):280-4. PubMed ID: 18525308
    [Abstract] [Full Text] [Related]

  • 2. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M, Martínez-Monge R, García-Foncillas J, Azinovic I, Aristu J, López-García G, Brugarolas A.
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [Abstract] [Full Text] [Related]

  • 3. Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1).
    Macchia G, Ferrandina G, Deodato F, Ruggieri V, Massaccesi M, Salutari V, Valentini V, Cellini N, Scambia G, Morganti AG.
    Gynecol Oncol; 2010 Aug 01; 118(2):128-33. PubMed ID: 20494419
    [Abstract] [Full Text] [Related]

  • 4. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan 01; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 5. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 01; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 6. Hyperfractionated radiation therapy plus chemotherapy in locally advanced cervical cancer: results of two phase I dose-escalation Gynecologic Oncology Group trials.
    Calkins AR, Harrison CR, Fowler WC, Gallion H, Mangan CE, Husseinzadeh N, Alvarez RD, Mychalczak B, Podczaski E.
    Gynecol Oncol; 1999 Dec 01; 75(3):349-55. PubMed ID: 10600288
    [Abstract] [Full Text] [Related]

  • 7. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, Monk BJ, O'Connor DM.
    J Clin Oncol; 2005 Nov 20; 23(33):8289-95. PubMed ID: 16230678
    [Abstract] [Full Text] [Related]

  • 8. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
    Stehman FB, Bundy BN, Kucera PR, Deppe G, Reddy S, O'Connor DM.
    Gynecol Oncol; 1997 Aug 20; 66(2):262-7. PubMed ID: 9264574
    [Abstract] [Full Text] [Related]

  • 9. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
    Distefano M, Ferrandina G, Smaniotto D, Margariti AP, Zannoni G, Macchia G, Manfredi R, Mangiacotti MG, Cellini N, Scambia G.
    Oncology; 2004 Aug 20; 67(2):103-11. PubMed ID: 15539913
    [Abstract] [Full Text] [Related]

  • 10. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
    Miglietta L, Franzone P, Centurioni MG, Boni L, Tacchini L, Cosso M, Boccardo F, Ferrarini M, Bruzzone M.
    Oncology; 2006 Aug 20; 70(1):19-24. PubMed ID: 16439862
    [Abstract] [Full Text] [Related]

  • 11. Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies.
    Mundt AJ, Rotmensch J, Waggoner S, Quiet C, Fleming G.
    Gynecol Oncol; 1999 Jan 20; 72(1):45-50. PubMed ID: 9889028
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant high-dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages IIIa-IVa cervical cancer.
    Motoyama S, Hamana S, Ku Y, Laoag-Fernandez JB, Deguchi M, Yoshida S, Tominaga M, Iwasaki T, Ohara N, Maruo T.
    Gynecol Oncol; 2004 Dec 20; 95(3):576-82. PubMed ID: 15581966
    [Abstract] [Full Text] [Related]

  • 13. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
    Johnson FM, Garden AS, Palmer JL, Shin DM, Morrison W, Papadimitrakopoulou V, Khuri F, Clayman G, Goepfert H, Ang KK, Hong WK, Glisson BS.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):717-24. PubMed ID: 16199307
    [Abstract] [Full Text] [Related]

  • 14. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
    DiSilvestro PA, Walker JL, Morrison A, Rose PG, Homesley H, Warshal D, Gynecologic Oncology Group.
    Gynecol Oncol; 2006 Dec 01; 103(3):1038-42. PubMed ID: 16889823
    [Abstract] [Full Text] [Related]

  • 15. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
    Prasad E, Viswanathan PN, Rangad VF, Pavamani S, Ram TS.
    Clin Oncol (R Coll Radiol); 2009 Aug 01; 21(6):488-93. PubMed ID: 19386478
    [Abstract] [Full Text] [Related]

  • 16. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS, Kim JH, Ahn SD, Lee SW, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1522-8. PubMed ID: 19231106
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer.
    Benedetti Panici P, Bellati F, Manci N, Pernice M, Plotti F, Di Donato V, Calcagno M, Zullo MA, Muzii L, Angioli R.
    Ann Surg Oncol; 2007 Sep 01; 14(9):2643-8. PubMed ID: 17562114
    [Abstract] [Full Text] [Related]

  • 18. Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1).
    Macchia G, Morganti AG, Deodato F, Cilla S, Lucidi A, Massaccesi M, Scambia G, Valentini V, Cellini N, Ferrandina G.
    Gynecol Oncol; 2012 Jun 01; 125(3):594-9. PubMed ID: 22425663
    [Abstract] [Full Text] [Related]

  • 19. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
    Pehlivan B, Luthi F, Matzinger O, Betz M, Dragusanu D, Bulling S, Bron L, Pasche P, Seelentag W, Mirimanoff RO, Zouhair A, Ozsahin M.
    Ann Surg Oncol; 2009 May 01; 16(5):1337-43. PubMed ID: 19280263
    [Abstract] [Full Text] [Related]

  • 20. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.